Philadelphia, PA, United States of America

Cynthia A Parrish

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 35(Granted Patents)

Location History:

King of Prussia, PA (US) (2009)
Philadelphia, PA (US) (2009 - 2014)
Collegeville, PA (US) (2009 - 2017)

Company Filing History:

Smithkline Beecham Corporation

patents

2 out of 92

Glaxosmithkline Intellectual Property (no.2) Limited

where one patent can have more than one assignee

Years Active: 2009-2017

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9725437 - Fatty acid synthase inhibitors (2017-08-08),

2. 9340529 - Triazolones as fatty acid synthase inhibitors (2016-05-17),

3. 9084794 - Fatty acid synthase inhibitors (2015-07-21),

4. 8802864 - Triazolones as fatty acid synthase inhibitors (2014-08-12),

5. 8772507 - Imidazole-benzamide anti-cancer agents (2014-07-08),

6. 8207340 - Imidazopyridinyl benzamide mitotic kinesin inhibitors (2012-06-26),

7. 8163919 - Imidazopyridinyl benzamide mitotic kinesin inhibitors (2012-04-24),

8. 7795448 - Imidazoyl-benzamide anti-cancer agents (2010-09-14),

9. 7618981 - Imidazopyridinyl-benzamide anti-cancer agents (2009-11-17),

10. 7592342 - Quinoxaline derivatives as PI3 kinase inhibitors (2009-09-22),

11. 7582668 - Imidazoyl-benzamide anti-cancer agents (2009-09-01),

12. 7504413 - N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases (2009-03-17),

13. 7495102 - Azaindole inhibitors of aurora kinases (2009-02-24),

Title: Cynthia A Parrish: Innovator in Fatty Acid Synthase Inhibition

Introduction

Cynthia A Parrish is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of fatty acid synthase inhibitors. With a total of 13 patents to her name, her work has the potential to impact cancer treatment significantly.

Latest Patents

Among her latest patents are two notable inventions related to fatty acid synthase inhibitors. The first patent focuses on triazolones and their role in modulating the activity of fatty acid synthase (FAS). This invention highlights the potential use of triazolones in cancer treatment. The second patent also centers on triazolone derivatives, emphasizing their application in inhibiting FAS activity, further supporting their use in cancer therapies.

Career Highlights

Cynthia has worked with several reputable companies throughout her career, including Cytokinetics, Inc. and SmithKline Beecham Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Nicholas D Adams and Dashyant Dhanak. Their collaborative efforts have likely enhanced the innovation and development of her patented technologies.

Conclusion

Cynthia A Parrish is a trailblazer in the field of fatty acid synthase inhibition, with a strong portfolio of patents that could revolutionize cancer treatment. Her work exemplifies the impact of innovative thinking in the medical and scientific communities.

This text is generated by artificial intelligence and may not be accurate.